No Data
No Data
*Special Treat Da Yao (603963.SH): As of August 9, 2024, the company has 17,582 shareholders.
On August 13th, Gelunhui reported that as of August 9th, 2024, the number of shareholders in the company was 17,582.
On August 7, A-share lightning rod: Guangdong Tecsun Science & Technology - controlling shareholder and actual controller Guo Xiaobin plans to reduce shareholding by no more than 3.00%; Guangdong Highsun Group - Shenzhen Stock Exchange plans to terminate
Guangdong Tecsun Science & Technology's controlling shareholder and actual controller Guo Xiaobin intends to reduce his shareholding by no more than 3.00%; ST Dayoutan announced the termination of the planned change of control and resumed trading from August 7; Guangdong Highsun Group received a notification from the Shenzhen Stock Exchange to terminate the company's stock trading; Jiangyin Hengrun Heavy Industries' shareholder Cheng Lixin's holding of 4.72% of the shares was judicially frozen.
* Special treat Da Yao (603963.SH): Termination of planned change of control, resuming trade from August 7th.
On August 6th, Glory Times reported that ST Dah Yao (603963.SH) received a notice from its controlling shareholder and actual controller Mr. Yang Junxiang on August 6th, 2024. During the trading suspension period, the controlling shareholder and actual controller Mr. Yang Junxiang and the counterparty did not reach a consensus on this transaction. After careful consideration, the controlling shareholder and actual controller Mr. Yang Junxiang decided to terminate the planning of this agreement to transfer the company's shares. After applying to the Shanghai Stock Exchange, the company's stocks will resume trading on August 7, 2024 (Wednesday).
Special treat Da Yao (603963.SH): planning changes in controlling stake, stocks suspended.
On August 5th, Gelunhui reported that *ST Pharma (603963.SH) has received notice that its controlling shareholder and actual controller, Mr. Yang Junxiang, is preparing for the agreement to transfer company shares, which may result in a change of the company's control. The company's stocks will continue to be suspended from August 6th, 2024 (Tuesday), and the total suspension time is expected not to exceed two trading days (including August 5th).
*ST Dapha (603963.SH): As of July 10th, 2024, the company has 16,811 shareholders.
On July 16th, Gelunhui reported that Special Treat Da Yao (603963.SH) stated on the investor interaction platform that the company has not received any relevant notice of changes in shareholding from major shareholders so far. If there are corresponding situations, the company will strictly fulfill its information disclosure obligations in a timely manner according to relevant regulations. As of July 10, 2024, there were 16,811 shareholders of the company.
Announcement of Dali Pharmaceutical Co., Ltd.'s anticipated half-year performance loss for 2024.
No Data